Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-13

Clinical Trial Update: Impact of OCT1 on Metformin Tolerance [Phase 4]

View source ↗

Summary

Phase 4 study examining how OCT1 transport influences metformin tolerability. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • metformin (metformin)

Snippet

Sponsor: NHS Tayside | Conditions: Tolerance | Phase 4 | Status: COMPLETED